Short Interest in OKYO Pharma Limited (NASDAQ:OKYO) Increases By 21.7%

OKYO Pharma Limited (NASDAQ:OKYO) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 48,300 shares, a growth of 21.7% from the June 30th total of 39,700 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is presently 2.2 days. Currently, 0.2% of the shares of the company are short sold.

OKYO Pharma Price Performance

OKYO traded up $0.01 during midday trading on Friday, hitting $1.36. 28,651 shares of the company were exchanged, compared to its average volume of 32,025. The company’s 50 day simple moving average is $1.37 and its 200 day simple moving average is $1.44. OKYO Pharma has a 1-year low of $1.09 and a 1-year high of $3.07.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 price target on shares of OKYO Pharma in a research report on Thursday, July 11th.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.